IBDEI0J0 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8920,1,4,0)
 ;;=4^MALE INFERTILITY NOS
 ;;^UTILITY(U,$J,358.3,8920,1,5,0)
 ;;=5^606.9
 ;;^UTILITY(U,$J,358.3,8920,2)
 ;;=^62833
 ;;^UTILITY(U,$J,358.3,8921,0)
 ;;=606.1^^38^502^4
 ;;^UTILITY(U,$J,358.3,8921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8921,1,4,0)
 ;;=4^OLIGOSPERMIA
 ;;^UTILITY(U,$J,358.3,8921,1,5,0)
 ;;=5^606.1
 ;;^UTILITY(U,$J,358.3,8921,2)
 ;;=^85449
 ;;^UTILITY(U,$J,358.3,8922,0)
 ;;=257.2^^38^502^5
 ;;^UTILITY(U,$J,358.3,8922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8922,1,4,0)
 ;;=4^TESTICULAR HYPOFUNC NEC
 ;;^UTILITY(U,$J,358.3,8922,1,5,0)
 ;;=5^257.2
 ;;^UTILITY(U,$J,358.3,8922,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,8923,0)
 ;;=302.72^^38^502^2
 ;;^UTILITY(U,$J,358.3,8923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8923,1,4,0)
 ;;=4^MALE ERECTILE DYSFUNCTION
 ;;^UTILITY(U,$J,358.3,8923,1,5,0)
 ;;=5^302.72
 ;;^UTILITY(U,$J,358.3,8923,2)
 ;;=^73439
 ;;^UTILITY(U,$J,358.3,8924,0)
 ;;=194.0^^38^503^3
 ;;^UTILITY(U,$J,358.3,8924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8924,1,4,0)
 ;;=4^ADRENAL TUMOR,MALIGNANT
 ;;^UTILITY(U,$J,358.3,8924,1,5,0)
 ;;=5^194.0
 ;;^UTILITY(U,$J,358.3,8924,2)
 ;;=^267298
 ;;^UTILITY(U,$J,358.3,8925,0)
 ;;=255.10^^38^503^6
 ;;^UTILITY(U,$J,358.3,8925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8925,1,4,0)
 ;;=4^ALDOSTERONISM,PRIMARY
 ;;^UTILITY(U,$J,358.3,8925,1,5,0)
 ;;=5^255.10
 ;;^UTILITY(U,$J,358.3,8925,2)
 ;;=^330019
 ;;^UTILITY(U,$J,358.3,8926,0)
 ;;=255.14^^38^503^5
 ;;^UTILITY(U,$J,358.3,8926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8926,1,4,0)
 ;;=4^ALDOSTERNISM,SECONDARY
 ;;^UTILITY(U,$J,358.3,8926,1,5,0)
 ;;=5^255.14
 ;;^UTILITY(U,$J,358.3,8926,2)
 ;;=^329907
 ;;^UTILITY(U,$J,358.3,8927,0)
 ;;=255.10^^38^503^14
 ;;^UTILITY(U,$J,358.3,8927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8927,1,4,0)
 ;;=4^HYPERALDOSTERONISM
 ;;^UTILITY(U,$J,358.3,8927,1,5,0)
 ;;=5^255.10
 ;;^UTILITY(U,$J,358.3,8927,2)
 ;;=^330019
 ;;^UTILITY(U,$J,358.3,8928,0)
 ;;=227.0^^38^503^16
 ;;^UTILITY(U,$J,358.3,8928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8928,1,4,0)
 ;;=4^PHEOCHROMOCYTOMA,BENIGN
 ;;^UTILITY(U,$J,358.3,8928,1,5,0)
 ;;=5^227.0
 ;;^UTILITY(U,$J,358.3,8928,2)
 ;;=^267688
 ;;^UTILITY(U,$J,358.3,8929,0)
 ;;=255.12^^38^503^8
 ;;^UTILITY(U,$J,358.3,8929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8929,1,4,0)
 ;;=4^CONN'S SYNDROME
 ;;^UTILITY(U,$J,358.3,8929,1,5,0)
 ;;=5^255.12
 ;;^UTILITY(U,$J,358.3,8929,2)
 ;;=^329905
 ;;^UTILITY(U,$J,358.3,8930,0)
 ;;=266.2^^38^503^7
 ;;^UTILITY(U,$J,358.3,8930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8930,1,4,0)
 ;;=4^B-COMPLEX DEFIC NEC
 ;;^UTILITY(U,$J,358.3,8930,1,5,0)
 ;;=5^266.2
 ;;^UTILITY(U,$J,358.3,8930,2)
 ;;=^87347
 ;;^UTILITY(U,$J,358.3,8931,0)
 ;;=255.0^^38^503^9
 ;;^UTILITY(U,$J,358.3,8931,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8931,1,4,0)
 ;;=4^CUSHING'S SYNDROME
 ;;^UTILITY(U,$J,358.3,8931,1,5,0)
 ;;=5^255.0
 ;;^UTILITY(U,$J,358.3,8931,2)
 ;;=^29802
 ;;^UTILITY(U,$J,358.3,8932,0)
 ;;=255.41^^38^503^11
 ;;^UTILITY(U,$J,358.3,8932,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8932,1,4,0)
 ;;=4^GLUCOCORTICOID DEFICIENT
 ;;^UTILITY(U,$J,358.3,8932,1,5,0)
 ;;=5^255.41
 ;;^UTILITY(U,$J,358.3,8932,2)
 ;;=^335240
 ;;^UTILITY(U,$J,358.3,8933,0)
 ;;=255.42^^38^503^15
 ;;^UTILITY(U,$J,358.3,8933,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8933,1,4,0)
 ;;=4^MINERALCORTICOID DEFCNT
 ;;^UTILITY(U,$J,358.3,8933,1,5,0)
 ;;=5^255.42
 ;;^UTILITY(U,$J,358.3,8933,2)
 ;;=^335241
 ;;^UTILITY(U,$J,358.3,8934,0)
 ;;=790.6^^38^503^1
 ;;^UTILITY(U,$J,358.3,8934,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8934,1,4,0)
 ;;=4^ABN BLOOD CHEMISTRY NEC
 ;;
 ;;$END ROU IBDEI0J0
